Bozer and his mother are tailgated by a mystery driver!
Bozer and his mother are tailgated by a mystery driver!
The Tampa Bay Buccaneers quarterback reacted to news that he'd be playing against his old team next season.
Futures signal a market rally rebound will continue. But what should you do now? Disney and Coinbase are earnings movers.
The "Facial Tissues Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.
Hundreds of Caixabank employees protested in Valencia on Friday against the bank's plans to cut staff numbers by nearly a fifth in Spain, just as shareholders were due to vote on bosses pay at the lender's annual meeting. TV footage released by the union CCOO on social media showed people, some wearing masks with faces of Caixabank executives, protesting outside Valencia's Palacio de Congresos, where the bank's shareholder meeting was taking place. A spokesman for the union Comisiones Obreras (CCOO) said 500 people had turned up in Valencia to protest against the bank's job cut plans.
WASHINGTON — A network of conservative activists, aided by a British former spy, mounted a campaign during the Trump administration to discredit perceived enemies of President Donald Trump inside the government, according to documents and people involved in the operations. The campaign included a planned sting operation against Trump’s national security adviser at the time, H.R. McMaster, and secret surveillance operations against FBI employees, aimed at exposing anti-Trump sentiment in the bureau’s ranks. The operations against the FBI, run by the conservative group Project Veritas, were conducted from a large home in the Georgetown section of Washington that rented for $10,000 per month. Female undercover operatives arranged dates with the FBI employees with the aim of secretly recording them making disparaging comments about Trump. Sign up for The Morning newsletter from the New York Times The campaign shows the obsession that some of Trump’s allies had about a shadowy “deep state” trying to blunt his agenda — and the lengths that some were willing to go to try to purge the government of those believed to be disloyal to the president. Central to the effort, according to interviews, was Richard Seddon, a former undercover British spy who was recruited in 2016 by security contractor Erik Prince to train Project Veritas operatives to infiltrate trade unions, Democratic congressional campaigns and other targets. He ran field operations for Project Veritas until mid-2018. Last year, The New York Times reported that Seddon ran an expansive effort to gain access to the unions and campaigns and led a hiring effort that nearly tripled the number of the group’s operatives, according to interviews and deposition testimony. He trained operatives at the Prince family ranch in Wyoming. The efforts to target American officials show how a campaign once focused on exposing outside organizations slowly morphed into an operation to ferret out Trump’s perceived enemies in the government’s ranks. Whether any of Trump’s White House advisers had direct knowledge of the campaign is unclear, but one of the participants in the operation against McMaster, Barbara Ledeen, said she was brought on by someone “with access to McMaster’s calendar.” At the time, Ledeen was a staff member of the Senate Judiciary Committee, then led by Sen. Chuck Grassley, R-Iowa. This account is drawn from more than a dozen interviews with former Project Veritas employees and others familiar with the campaign, along with current and former government officials and internal Project Veritas documents. The scheme against McMaster, revealed in interviews and documents, was one of the most brazen operations of the campaign. It involved a plan to hire a woman armed with a hidden camera to capture McMaster making inappropriate remarks that his opponents could use as leverage to get him ousted as national security adviser. Although several Project Veritas operatives were involved in the plot, it is unclear whether the group directed it. The group, which is a nonprofit, has a history of conducting sting operations on news organizations, Democratic politicians and advocacy groups. The operation was ultimately abandoned in March 2018 when the conspirators ended up getting what they wanted, albeit by different means. The embattled McMaster resigned on March 22, a move that avoided a firing by the president who had soured on the three-star general. Project Veritas did not respond to specific questions about the operations. On Thursday, James O’Keefe, the head of the group, said this article was “a smear piece.” “Because The New York Times is losing to Project Veritas in a court of law, it is trying to smear Project Veritas in the court of public opinion,” he said. “I think the court, like me, may well be appalled at The New York Times’ continued pattern of defamation of Project Veritas.” He also released a video. Project Veritas sued The Times for defamation last year over coverage of one of the group’s videos. Neither Seddon nor Prince responded to requests for comment. McMaster declined to comment. When confronted with details about her involvement in the McMaster operation, Ledeen insisted that she was merely a messenger. “I am not part of a plot,” she said. Scheme Against McMaster The operation against McMaster was hatched not long after an article appeared in BuzzFeed News about a private dinner in 2017. Exactly what happened during the dinner is in dispute, but the article said that McMaster had disparaged Trump by calling him an “idiot” with the intelligence of a “kindergartner.” That dinner, at an upscale restaurant in downtown Washington, was attended by McMaster and Safra Catz, the chief executive of Oracle, as well as two of their aides. Not long after, Catz called Donald McGahn, then the White House counsel, to complain about McMaster’s behavior, according to two people familiar with the call. White House officials investigated and could not substantiate her claims, people familiar with their inquiry said. Catz declined to comment, and there is no evidence that she played any role in the plot against McMaster. Soon after the BuzzFeed article, however, the scheme developed to try to entrap McMaster: Recruit a woman to stake out the same restaurant, Tosca, with a hidden camera. According to the plan, whenever McMaster returned by himself, the woman would strike up a conversation with him and, over drinks, try to get him to make comments that could be used to either force him to resign or get him fired. Who initially ordered the operation is unclear. In an interview, Ledeen said “someone she trusted” contacted her to help with the plan. She said she could not remember who. “Somebody who had his calendar conveyed to me that he goes to Tosca all the time,” she said of McMaster. According to Ledeen, she passed the message to a man she believed to be a Project Veritas operative during a meeting at the University Club in Washington. Ledeen said she believed the man provided her with a fake name. By then, McMaster already had a raft of enemies among Trump loyalists, who viewed him as a “globalist” creature of the so-called deep state who was committed to policies they vehemently opposed, like remaining committed to a nuclear deal with Iran and keeping American troops in Afghanistan. The president often stoked the fire, railing against national security officials at the CIA, FBI, State Department and elsewhere who he was convinced were trying to undermine him. These “unelected deep-state operatives who defy the voters to push their own secret agendas,” he said in 2018, “are truly a threat to democracy itself.” Seddon recruited Tarah Price, who at one point was a Project Veritas operative, and offered to pay her thousands of dollars to participate in the operation, according to interviews and an email written by a former boyfriend of Price and sent to Project Veritas Exposed, a group that tries to identify the group’s undercover operatives. The May 2018 email, a copy of which was obtained by The Times, said that Price was “going to get paid $10,000 to go undercover and set up some big-name political figure in Washington.” It was unclear who was funding the operation. Price’s former boyfriend was apparently unaware of the target of the operation, or that McMaster had been forced to step down in March. Two people identified the political figure as McMaster. Price did not respond to requests for comment. Ledeen was a longtime staff member for the Judiciary Committee who had been part of past operations in support of Trump. In 2016, she was involved in a secret effort with Michael Flynn — who went on to become Trump’s first national security adviser — to hunt down thousands of emails that had been deleted from Hillary Clinton’s private email server. According to the report by the special counsel, Robert Mueller, Ledeen had prepared a 25-page proposal about how to obtain what she believed were “classified emails” that had already been “purloined by our enemies.” The exchange was included in emails the special counsel obtained during the investigation. Ledeen later claimed to have obtained the deleted Clinton emails from the dark web and sought Prince’s assistance to authenticate them. “Erik Prince provided funding to hire a tech adviser to ascertain the authenticity of the emails. According to Prince, the tech adviser determined that the emails were not authentic,” the special counsel’s report said. She is part of a network of conservative activists who had particular influence in the Trump White House. She is a member of one group, Groundswell, that pushed to purge the White House and other government agencies of “deep state” enemies of Trump. Last year, Axios reported that a memo written by Ledeen — laying out a case against a nominee for a top job in the Treasury Department — was instrumental in Trump’s decision to withdraw the nomination. Barbara Ledeen is married to Michael Ledeen, who wrote the 2016 book “The Field of Fight” with Flynn. She said she retired from the Senate earlier this year. After Flynn resigned under pressure as national security adviser, Trump gave the job to McMaster — inciting the ire of loyalists to Flynn. Ledeen posted numerous negative articles about McMaster on her Facebook page. After The Times published its article about Prince’s work with Project Veritas, she wrote on Facebook, “We owe a lot to Erik Prince.” A Former Spy’s Role Seddon first came to know Prince in the years after the Sept. 11, 2001, attacks, when he was stationed at the British Embassy in Washington and Prince’s company, Blackwater, was winning large American government contracts for work in Afghanistan and Iraq. Former colleagues of Seddon said he nurtured a love of the American West, and of the country’s gun culture. He is married to a longtime State Department officer, Alice Seddon, who retired last year. After Seddon joined Project Veritas, he set out to professionalize what was once a small operation with a limited budget. He hired former soldiers, a former FBI agent and a British former commando. Documents obtained by The Times show the extent that Seddon built espionage tactics into training for the group’s operatives — teaching them to use deception to secure information from potential targets. One role-playing exercise involved a trainee being interrogated by a law enforcement officer and having to “defend their cover” and “avoid exciting” the officer. Another exercise instructs trainees in how to target a person in an elevator. The students were encouraged to think of their “targets as a possible future access agent, potential donor, support/facilities agent.” “The student must create and maintain a fictional cover,” one document read. The early training for the operations took place at the Prince family ranch near Cody, Wyoming, and Seddon and his colleagues conducted hiring interviews inside an airport hangar at the Cody airport known locally as the Prince hangar, according to interviews and documents. Prince is the brother of Betsy DeVos, who served as Trump’s education secretary. During the interview process, candidates fielded questions meant to figure out their political leanings, including which famous people they might invite to a dinner party and which publications they get their news from. After finishing the exercises, the operatives were told to burn the training materials, according to a former Project Veritas employee. Project Veritas also experienced a windfall during the Trump administration, with millions in donations from private donors and conservative foundations. In 2019, the group received a $1 million contribution made through the law firm Alston & Bird, according to a financial document obtained by The Times. The firm has declined to say on whose behalf the contribution was made. That same year, Project Veritas also received more than $4 million through DonorsTrust, a nonprofit used by conservative groups and individuals. Targeting FBI Employees Around the time McMaster resigned, Seddon pushed for Project Veritas to establish a base of operations in Washington and found a six-bedroom estate near the Georgetown University campus, according to former Project Veritas employees. The house had a view of the Potomac River and was steps from the dark, narrow staircase made famous by the film “The Exorcist.” The group used a shell company to rent it, according to Project Veritas documents and interviews. The plan was simple: Use undercover operatives to entrap FBI employees and other government officials who could be publicly exposed as opposing Trump. The group has previously assigned female operatives to secretly record and discredit male targets — sometimes making first contact with them on dating apps. In 2017, a Project Veritas operative also approached a Washington Post reporter with a false claim that a Senate candidate had impregnated her. During the Trump administration, the FBI became an attractive target for the president’s allies. In late 2017, news reports revealed that a senior FBI counterintelligence agent and a lawyer at the bureau who were working on the Russia investigation had exchanged text messages disparaging Trump. The president’s supporters and allies in Congress said the texts were proof of bias at the FBI and that the sprawling Russia inquiry was just a plot by the “deep state” to derail the Trump presidency. Project Veritas operatives created fake profiles on dating apps to lure the FBI employees, according to two former Project Veritas employees and a screenshot of one of the accounts. They arranged to meet and arrived with a hidden camera and microphone. Women living at the house had Project Veritas code names, including “Brazil” and “Tiger,” according to three former Project Veritas employees with knowledge of the operations. People living at the house were told not to receive mail using their real names. If they took an Uber home, the driver had to stop before they reached the house to ensure nobody saw where they actually lived, one of the former Project Veritas employees said. One woman living at the house, Anna Khait, was part of several operations against various targets, including a State Department employee. Project Veritas released a video of the operation in 2018, saying it was the first installment in “an undercover video investigation series unmasking the deep state.” In the video, O’Keefe said Project Veritas had been investigating the deep state for more than a year. He did not mention efforts to target the FBI. A former Project Veritas employee and another person identified the woman who targeted the State Department employee as Khait, who had appeared on the television show “Survivor.” Khait did not respond to a request for comment. By the time Project Veritas released its first “deep state” video, Seddon had left the group for other ventures — chafing at what he viewed as O’Keefe’s desire to produce quick media content rather than to run long-term infiltration operations, three former Project Veritas employees said. He was replaced by Tom Williams, a longtime associate of Prince’s, two of the former Project Veritas employees said. Williams also eventually left the group. O’Keefe has long defended his group’s methods. In his 2018 book, “American Pravda,” O’Keefe wrote that a “key distinction between the Project Veritas journalist and establishment reporters” is that “while we use deception to gain access, we never deceive our audience.” This article originally appeared in The New York Times. © 2021 The New York Times Company
In a 28-second video, which was posted to Twitter this week by a spokesman for Prime Minister Benjamin Netanyahu of Israel, Palestinian militants in the Gaza Strip appeared to launch rocket attacks at Israelis from densely populated civilian areas. At least that is what Netanyahu’s spokesman, Ofir Gendelman, said the video portrayed. But his tweet with the footage, which was shared hundreds of times as the conflict between Palestinians and Israelis escalated, was not from Gaza. It was not even from this week. Instead, the video that he shared, which can be found on many YouTube channels and other video-hosting sites, was from 2018. And according to captions on older versions of the video, it showed militants firing rockets not from Gaza but from Syria or Libya. Sign up for The Morning newsletter from the New York Times The video was just one piece of misinformation that has circulated on Twitter, TikTok, Facebook, WhatsApp and other social media this week about the rising violence between Israelis and Palestinians, as Israeli military ground forces attacked Gaza early Friday. The false information has included videos, photos and clips of text purported to be from government officials in the region, with posts baselessly claiming early this week that Israeli soldiers had invaded Gaza, or that Palestinian mobs were about to rampage through sleepy Israeli suburbs. The lies have been amplified as they have been shared thousands of times on Twitter and Facebook, spreading to WhatsApp and Telegram groups that have thousands of members, according to an analysis by The New York Times. The effect of the misinformation is potentially deadly, disinformation experts said, inflaming tensions between Israelis and Palestinians when suspicions and distrust have already run high. “A lot of it is rumor and broken telephone, but it is being shared right now because people are desperate to share information about the unfolding situation,” said Arieh Kovler, a political analyst and independent researcher in Jerusalem who studies misinformation. “What makes it more confusing is that it is a mix of false claims and genuine stuff, which is being attributed to the wrong place or the wrong time.” Twitter, TikTok and Facebook, which owns Instagram and WhatsApp, did not respond to requests for comment. Christina LoNigro, a spokeswoman for WhatsApp, said the company had put limits on how many times people could forward a message as a way of clamping down on misinformation. The Times found several pieces of misinformation that spread across Israeli and Palestinian neighborhood and activist WhatsApp groups this week. One, which appeared as a block of Hebrew text or an audio file, contained a warning that Palestinian mobs were preparing to descend on Israeli citizens. “Palestinians are coming, parents protect your children,” read the message, which pointed specifically to several suburban areas north of Tel Aviv. Thousands of people were in one of the Telegram groups where the post was shared; the post then appeared in several WhatsApp groups, which had dozens to hundreds of members. Israeli police did not respond to a request for comment. There were no reports of violence in the areas mentioned in the message. In another post early this week, which was written in Arabic and sent to a WhatsApp group with over 200 members, warnings flashed that Israeli soldiers were set to invade the Gaza Strip. “The invasion is coming,” read the text, which urged people to pray for their families. Arabic and Hebrew-language news sources also appeared to amplify some misinformation. Several Israeli news outlets recently discussed a video that showed a family walking to a funeral with a wrapped body, only to drop the body when a police siren sounded. The video was cited by the news organizations as evidence that Palestinian families were holding fake funerals and exaggerating the number of people killed in the conflict. In fact, the video appeared on YouTube over a year ago and may have shown a Jordanian family holding a fake funeral, according to a caption left on the original video. Clips of another video showing religious Jews tearing their clothing as a sign of devotion also circulated on Arabic-language news sites this week. The clips were cited as evidence that Jews were faking their own injuries in clashes in Jerusalem. That was false. The video had been uploaded to WhatsApp and Facebook several times earlier this year, according to The Times analysis. There is a long history of misinformation being shared among Israeli and Palestinian groups, with false claims and conspiracies spiking during moments of heightened violence in the region. In recent years, Facebook has removed several disinformation campaigns by Iran aimed at stoking tensions among Israelis and Palestinians. Twitter also took down a network of fake accounts in 2019 that was used to smear opponents of Netanyahu. The grainy video that Gendelman shared on Twitter on Wednesday, which purportedly showed Palestinian militants launching rocket attacks at Israelis, was removed Thursday after Twitter labeled it “misleading content.” Gendelman’s office did not respond to a request for comment. Gendelman appears to have mischaracterized the contents of other videos as well. On Tuesday, he posted a video on Twitter showing three adult men being instructed to lie on the floor, with their bodies being arranged by a crowd nearby. Gendelman said the video showed Palestinians staging bodies for a photo opportunity. Kovler, who traced the video back to its source, said the video had been posted in March to TikTok. Its accompanying text said the footage showed people practicing for a bomb drill. This article originally appeared in The New York Times. © 2021 The New York Times Company
LAS VEGAS, NV, May 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company with commercial operations in Telehealth and Cryptocurrency Mining, is pleased to announce that the Company’s Board of Directors has officially approved a significant share buyback program for immediate activation. The size of the Buyback program has been initially set at up to $250k, but may be expanded in the future. “We have substantial cash reserves, strong growth expectations, and expanding productive resources targeting rapidly growing end markets, as well as an absolute commitment to delivering shareholder value over the long term,” stated Alonzo Pierce, President and Chairman of ISW Holdings. Management notes the Company has strengthened its balance sheet considerably over recent quarters through non-toxic fundraising and cash flows from operations. The Company believes its equity to be undervalued relative to growth potential given recent investments in cryptocurrency mining capacity and telehealth operations. Pierce added, “We feel our shares no longer properly reflect the prepotency and growth potential inherent in our investments and market positioning. Our commitment is to the utilization of available resources toward the maximization of shareholder value within the purview of the Company’s mission. At this point, that implies the deployment of some portion of cash reserves toward the repurchasing of ISWH shares.” About ISW Holdings ISW Holdings, Inc. (ISWH), based in Nevada, is a diversified portfolio company comprised of essential business lines that serve consumer product demands. Our expertise lies in strategic brand development, early growth facilitation, as well as brand identity through our proprietary procurement process. Together, with our partners, we seek to provide a structure that meets large scalability demands, as well as anticipated marketplace needs. We are able to meet these needs through a variety of strategic innovative processes. ISWH is creating and managing brands across a spectrum of disruptive industries. It maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go-to-market strategies, engineering, product integration, and distribution efficiency. The company has also partnered with a well-known software development and consulting company, Bengala Technologies LLC, which is developing significant enhancements in the supply chain management space; and the partnership has a vitally needed patent now pending. For more information, visit www.iswholdings.com Forward Looking Statements This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could", "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company's reports filed from time to time with OTC Markets (www.otcmarkets.com). Company Contact:info@ISWHoldings.com Public RelationsEDM Media, LLChttps://edm.media
More than a year after federal health officials told Americans to cover their faces when venturing out in public, the Centers for Disease Control and Prevention said on Thursday that fully vaccinated people could start taking off their masks indoors. But the new federal guidance — announced amid a sharp decline in coronavirus cases and an expansion of vaccine eligibility to everyone 12 and older — came with caveats and confusion. And it sent state and local officials, as well as private companies, scrambling to decide whether and when to update their own rules. Here are some questions you might have about what the CDC’s new stance means, and what it doesn’t mean. Sign up for The Morning newsletter from the New York Times Does this mean masks are no longer recommended anywhere? Not quite. The federal guidance is expansive: Fully vaccinated people — those who have received their final COVID-19 vaccination at least two weeks ago — no longer need to wear masks outdoors or in most indoor settings. But there are limits. The agency was not specific about masking in some settings, including schools. And even fully vaccinated people are still told to cover their faces when visiting health care facilities, while flying or taking public transit, and in congregate settings such as homeless shelters, as well as prisons or jails. What does this mean for local mask mandates? The CDC advice does not override mask orders issued by states, counties or cities. But in the hours after the new policy was announced Thursday, officials in some parts of the country began to adjust their rules to align with federal guidance. Others had yet to weigh in publicly, and some said they were keeping their rules in place while they reviewed the CDC’s suggestions. As the guidance filtered out around the country, officials began issuing announcements — a patchwork of plans, as so much of the nation’s pandemic response has been over the last year. Officials in Pennsylvania said they had changed the state’s mask mandate to exempt fully vaccinated people, and Gov. Andy Beshear of Kentucky and Gov. J.B. Pritzker of Illinois, both Democrats, indicated that they would do the same. The chief executive in St. Louis County, Missouri, said he was also working to update local restrictions. Elsewhere, including in Wichita, Kansas, New York state, New York City and New Jersey, officials said they were reviewing the new guidelines but were not yet announcing any changes. In the counties that include Las Vegas and Lawrence, Kansas, officials said they would discuss their rules at meetings next week. Was this a surprise? The news stunned health experts, political leaders, business owners — and seemingly everyone else. Only 2-1/2 weeks ago, the CDC had given a far milder directive, saying that fully vaccinated people could remove their masks outdoors but not in crowded spaces. “It feels like a huge shift, and I’m not going to follow it,” said Dr. John Swartzberg, an infectious-disease specialist and clinical professor emeritus at the University of California, Berkeley’s School of Public Health. “The most important point is that the CDC is putting responsibility back on individuals. Each individual should look at what the CDC is recommending and see if that fits for them.” Swartzberg said he would continue to be unmasked while outdoors but would carry a mask with him to wear indoors in public spaces. “This shows tremendous confidence in how well the vaccines work,” he said. “The CDC does have data to support this decision. It’s not like they’re operating on the fly.” Why now? It was not entirely clear what prompted the new guidance on Thursday. Cases, hospitalizations and deaths have been trending downward in the United States for weeks. About 37,000 cases are being identified each day, the fewest since September, and about 630 deaths are being announced daily, the lowest average since July. But the most significant change is the availability of vaccines. Everyone age 16 and older has been eligible for a vaccine for weeks, and those ages 12 to 15 became eligible for the Pfizer-BioNTech vaccine this week. About 47% of people in the United States have received at least one vaccine dose, and appointments are readily available across most of the country. Some public health experts said they viewed the new mask guidance, in part, as an incentive to entice those who have not gotten shots: Getting vaccinated would mean no longer having to wear a mask. “We have all longed for this moment,” Dr. Rochelle Walensky, director of the CDC, said at a White House news conference Thursday. “If you are fully vaccinated, you can start doing the things that you had stopped doing because of the pandemic.” What does all this mean for stores and restaurants? The new policy seemed to catch many retailers and their workers by surprise. Macy’s and the Gap said they were still reviewing the new guidance, while Home Depot said it had no plans to change its current rules requiring customers and workers to wear masks in its stores. Other major retailers, including Walmart, did not immediately respond to requests for comment, while officials at Target said they would keep in place mask and distancing rules while reviewing the CDC guidance. The United Food and Commercial Workers union, representing thousands of grocery store workers, criticized the CDC for failing to consider how the new policy would affect workers who have to deal with customers who are not vaccinated. And the Retail Industry Leaders Association, a trade group, said the policy complicated matters in states that still have mask mandates in place that retailers must follow. But how do you know whether a stranger shopping or eating next to you is vaccinated? You probably won’t. About 36% of people in the United States are fully vaccinated, and there is no way to tell them apart from the 64% of people who are not. People who receive a vaccine are issued a white paper card, but online scammers have sold forged versions of those. The new guidance reopened discussions of so-called vaccine passports, which would certify someone’s vaccination status. Efforts to create a more robust system of such passports have been largely derailed in the United States by concerns about privacy and backlash from Republican politicians. New York state has created its own version of a vaccine passport. What has the CDC’s guidance been on masks all along? At the very beginning of the pandemic, the CDC.’s position was that most ordinary people did not need to wear masks unless they were sick and coughing. At the time, there was limited understanding that the virus was airborne and could be transmitted by people who were asymptomatic, and there was also a concern that recommending masks would worsen an N95 mask shortage for health care workers. But the CDC’s position quickly shifted. By April 2020, the CDC urged all Americans to wear a mask when they left their homes. The guidance kept changing throughout the pandemic. For example, the agency first said that wearing masks protected others, not the wearer. By November, officials went a step further, saying masks benefited the people who wear them, in addition to those around them. With vaccinations ramping up, the CDC began to loosen its guidance last month, advising that fully vaccinated people could remove their masks in many situations outdoors, where the virus spreads less easily. Then Thursday, the CDC announced that the relaxed rules also applied indoors. I’m vaccinated. So what am I supposed to do right now? If you feel comfortable doing so, you can start going out without a mask on your face. But you might want to still keep one in your pocket. Some local governments and businesses are likely to continue requiring masks, at least in the immediate future. And if you ride the bus or train, or are visiting a family member in a hospital or nursing home, you will still be expected to mask up. This article originally appeared in The New York Times. © 2021 The New York Times Company
Be prepared to be fined $300 if you do not clear your dirty tray, crockery and litter at a table after a meal at any hawker centre from 1 September.
The 2021 Stanley Cup playoffs will be a step toward normalcy, but there are still a few new format wrinkles that we haven't seen in recent years.
Thousands protest against racism and police violence, a week after a deadly raid in a slum in Rio.
One in five people are more comfortable talking about grief due to the pandemic, new research reveals.
Kopin® Corporation (NASDAQ: KOPN), a leading developer and provider of transmissive and reflective active matrix liquid crystal and organic light emitting diode (OLED) microdisplays used in military, enterprise, industrial, medical and consumer products, is pleased to announce that the first and second segments of its webinar on SmartGlasses hosted by Insight Media drew over 500 participants.
The "Global Ambulatory Blood Pressure Monitoring Systems Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that on May 11, 2021, the Compensation Committee of the Company’s Board of Directors granted a newly hired employee the option to purchase 175,000 shares of the Company's common stock and restricted stock units (RSUs) covering 100,000 shares of the Company’s common stock. These equity awards were granted pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules as an inducement material to the employee’s acceptance of employment with the Company.
Topline efficacy and safety data from pivotal Phase 3 NORSE TWO study on target to report in calendar Q3 2021Recently reported topline data from the NORSE THREE open-label safety study reinforce positive safety profile of ONS-5010 seen in the earlier clinical experience trial (NORSE ONE) ISELIN, N.J., May 14, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced recent corporate highlights and financial results for its fiscal second quarter ended March 31, 2021.Outlook Therapeutics also provided a clinical development and pre-commercialization update on ONS-5010 / LYTENAVA™ (bevacizumab-vikg), its investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD) and other retinal indications.“Outlook Therapeutics continues to advance ONS-5010 towards a BLA filing for wet AMD. Having reported promising results from two of the three clinical trials for our planned BLA, we are now in the home stretch and focused on the topline data readout next quarter from NORSE TWO, our pivotal Phase 3 study,” commented Lawrence A. Kenyon, President, CEO and CFO of Outlook Therapeutics. “Additionally, with the funds raised in February, we are well positioned to complete NORSE TWO and prepare the BLA. We are excited about the upcoming clinical milestones and look forward to providing future updates as we continue to advance ONS-5010.” Recent Corporate Highlights Reported positive topline results from the open-label safety study (NORSE THREE), which demonstrated that ONS-5010 showed no unexpected safety trends and had a safety profile consistent with that of prior published data on the use of bevacizumab for ophthalmic conditions, such as the 2011 CATT study undertaken by the National Eye Institute; andReceived aggregate gross proceeds of $46.2 million from public offerings and private placements of common stock plus warrant exercises in February 2021. Financial Highlights for the Fiscal Second Quarter Ended March 31, 2021For the fiscal second quarter ended March 31, 2021, Outlook Therapeutics reported a net loss attributable to common stockholders of $13.1 million, or $0.09 per basic and diluted share, compared to a net loss attributable to common stockholders of $17.5 million, or $0.36 per basic and diluted share for the same period last year. At March 31, 2021, Outlook Therapeutics had cash and cash equivalents of $37.2 million, compared to $5.6 million at December 31, 2020. With the $42.6 million in gross proceeds received from the public offerings and private placements of common stock in February 2021, plus an additional $3.6 million received from warrant exercises also in February 2021, Outlook Therapeutics’ cash and cash equivalents on hand are sufficient to fund operations through November 2021. ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Development Updates In March 2021, Outlook Therapeutics announced topline results from its NORSE THREE open-label safety study evaluating ONS-5010 to treat retinal diseases. Topline results from that study demonstrated that ONS-5010 showed no unexpected safety trends and had a safety profile consistent with that of prior published data on the use of bevacizumab for ophthalmic conditions, such as the 2011 CATT study undertaken by the National Eye Institute. The safety endpoints for NORSE THREE were the frequency and incidence of treatment-emergent adverse events and an evaluation of changes in safety parameters. In the study, 20 out of 197 patients (10%) experienced an adverse event in the study eye that were most commonly associated with the injection procedure and not ONS-5010. There were no serious adverse events associated with treatment. Notably, there were zero cases of ocular inflammation, a concern that has emerged for some other anti-VEGF (Vascular Endothelial Growth Factor) therapies used to treat retinal conditions.Outlook Therapeutics completed patient enrollment for its pivotal Phase 3 clinical trial (NORSE TWO) in July 2020, enrolling a total of 228 patients at 39 clinical trial sites in the United States. Patients in the trial are being treated for 12 months. The primary endpoint for the study is the difference in proportion of patients who gain at least 15 letters in the best corrected visual acuity (BCVA) at 11 months for ONS-5010 dosed on a monthly basis, compared to LUCENTIS®, which is being dosed quarterly per the PIER regimen. Outlook Therapeutics expects to report pivotal safety and efficacy data in the third quarter of calendar 2021. Following the data readout of the pivotal NORSE TWO safety and efficacy study next quarter, Outlook Therapeutics plans to submit a new biologics license application (BLA) filing under the PHSA 351(a) regulatory pathway in the first quarter of calendar 2022. If the BLA is approved, it will result in 12 years of marketing exclusivity for ONS-5010 as the first and only ophthalmic formulation of bevacizumab to treat wet AMD approved by the U.S. Food and Drug Administration (FDA). Commercial launch planning for ONS-5010 has begun, including manufacturing, distribution, physician and patient outreach, and engagement with key opinion leaders and the payor community. With potential for an enhanced safety and cost-effectiveness profile, ONS-5010, if approved, is well positioned to become the first-line drug of choice in the United States for retinal indications and to be widely adopted by payors and clinicians worldwide in the $13.1 billion global anti-VEGF market. In addition to the clinical development plan evaluating ONS-5010 for wet AMD, Outlook Therapeutics has received agreements from the FDA on three Special Protocol Assessments (SPAs) for three additional registration clinical trials. These SPAs cover the protocols for a planned registration clinical trial evaluating ONS-5010 to treat branch retinal vein occlusion (BRVO, NORSE FOUR), and two planned registration clinical trials evaluating the drug candidate for the treatment of diabetic macular edema (DME, NORSE FIVE and NORSE SIX). Outlook Therapeutics expects to initiate registration clinical trials for ONS-5010 for DME and BRVO later in calendar 2021 or in early calendar 2022. About ONS-5010 / LYTENAVA™ (bevacizumab-vikg) ONS-5010 is an investigational ophthalmic formulation of bevacizumab under development to be administered as an intravitreal injection for the treatment of wet AMD and other retinal diseases. Because no currently approved ophthalmic formulations of bevacizumab are available, clinicians wishing to treat retinal patients with bevacizumab have had to use unapproved repackaged IV bevacizumab provided by compounding pharmacists, products that have known risks of contamination and inconsistent potency and availability. If approved, ONS-5010 will reduce the need for use of unapproved repackaged IV bevacizumab from compounding pharmacists for retinal disease. ONS-5010 is a full-length, humanized anti-VEGF (Vascular Endothelial Growth Factor) recombinant monoclonal antibody (mAb) that inhibits VEGF and associated angiogenic activity. VEGF is a protein that promotes the growth of new abnormal blood vessels. With wet AMD, abnormally high levels of VEGF are secreted in the eye and lead to loss of vision. Anti-VEGF injection therapy blocks this growth. Since the advent of anti-VEGF therapy, it has become the standard-of-care treatment option within the retina community globally. About Outlook Therapeutics, Inc. Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop ONS-5010 / LYTENAVA™ (bevacizumab) as the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet AMD, DME and BRVO. If ONS-5010 ophthalmic bevacizumab is approved, Outlook Therapeutics expects to commercialize it as the first and only FDA-approved ophthalmic formulation of bevacizumab for use in treating a range of retinal diseases in the United States, United Kingdom, Europe, Japan, China and other markets. Outlook Therapeutics expects to file ONS-5010 ophthalmic bevacizumab with the U.S. FDA as a new BLA under the PHSA 351(a) regulatory pathway, initially for wet AMD. For more information, please visit www.outlooktherapeutics.com. Forward-Looking Statements This press release contains forward-looking statements. All statements other than statements of historical facts are “forward-looking statements,” including those relating to future events. In some cases, you can identify forward-looking statements by terminology such as “expect,” “plan,” “anticipate,” “may,” “might,” “will,” “should,” “project,” “believe,” “estimate,” “predict,” “potential,” “intend” or “continue,” the negative of terms like these or other comparable terminology, and other words or terms of similar meaning. These include statements about the timing of topline data from, NORSE TWO, , Outlook Therapeutics’ cash runway, plans for BLA submission, , statements about Outlook Therapeutics’ other planned clinical trials for ONS-5010, ONS-5010’s potential as the first FDA-approved ophthalmic formulation of bevacizumab, including benefits therefrom to patients, payors and physicians, including expectations regarding market exclusivity, as well as plans for regulatory approvals in other markets. Although Outlook Therapeutics believes that it has a reasonable basis for the forward-looking statements contained herein, they are based on current expectations about future events affecting Outlook Therapeutics and are subject to risks, uncertainties and factors relating to its operations and business environment, all of which are difficult to predict and many of which are beyond its control. These risk factors include those risks associated with developing pharmaceutical product candidates, risks of conducting clinical trials and risks in obtaining necessary regulatory approvals, as well as those risks detailed in Outlook Therapeutics’ filings with the Securities and Exchange Commission, which include the uncertainty of future impacts related to the ongoing COVID-19 pandemic. These risks may cause actual results to differ materially from those expressed or implied by forward-looking statements in this press release. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Outlook Therapeutics does not undertake any obligation to update, amend or clarify these forward-looking statements whether as a result of new information, future events or otherwise, except as may be required under applicable securities law. For additional details on Outlook Therapeutics’ financial performance during the quarter, please see the Outlook Therapeutics filings with the Securities and Exchange Commission. CONTACTS: Media Inquiries: Harriet UllmanAssistant Vice PresidentLaVoieHealthScienceT: email@example.com Investor Inquiries: Jenene ThomasChief Executive OfficerJTC Team, LLCT: 833.475.8247OTLK@jtcir.com Outlook Therapeutics, Inc. Consolidated Statements of Operations (Amounts in thousands, except share data) Three months ended March 31, Six months ended March 31, 2021 2020 2021 2020 Operating expenses: Research and development $8,529 $4,383 $20,478 $10,231 General and administrative 4,096 1,958 6,338 4,294 Impairment of property and equipment - 423 - 423 12,625 6,764 - 26,816 - 14,948 Loss from operations (12,625) (6,764) (26,816) (14,948) Interest expense, net 251 696 410 1,294 Loss on extinguishment of debt - - - 8,060 Change in fair value of redemption feature - (1,759) - (1,797) Change in fair value of warrant liability 229 (1) 334 (202) Loss before income taxes (13,105) (5,700) (27,560) (22,303) Income tax expense 2 - 2 - Net loss (13,107) (5,700) (27,562) (22,303) Series A-1 convertible preferred stock dividends and related settlement - - - (166) Deemed dividend upon modification of warrants - (1,432) - (3,140) Deemed dividend upon amendment of the terms of the Series A-1 convertible preferred stock - (10,328) - (10,328) Net loss attributable to common stockholders $(13,107) $(17,460) $(27,562) $(35,937) Per share information: Net loss per share of common stock, basic and diluted $(0.09) $(0.36) $(0.20) $(0.93) Weighted average shares outstanding, basic and diluted 150,730 47,896 136,081 38,849 Consolidated Balance Sheet Data(Amounts in thousands) March 31, September 30, 2021 2020Cash $37,169 $12,536Total assets $45,112 $19,733Current liabilities $23,898 $15,889Total stockholders' equity (deficit) $20,651 $2,826
Harmonic (NASDAQ: HLIT) today announced that Sanjay Kalra, Harmonic's Chief Financial Officer, and Jeremy Rosenberg, Harmonic's Senior Vice President of Business Development, will participate in a fireside chat at the 16th Annual Needham Virtual Technology & Media Conference on Thursday, May 20, 2021 at 11:15 AM PT / 2:15 PM ET.
Jana Kramer is showing off the final results of her breast augmentation with a topless photo.
The CDC released new mask guidance on Thursday, but what does that mean for schools?
The convictions of two more former Post Office branch managers - wrongly accused of theft - have been quashed.